The Role of Vitamin D, Myo-Inositol, and Melatonin in the Redox-Endocrine Network of PCOS: Exploring Their Potential Synergistic Effects - Scorecard - MDSpire

The Role of Vitamin D, Myo-Inositol, and Melatonin in the Redox-Endocrine Network of PCOS: Exploring Their Potential Synergistic Effects

  • By

  • Subakathulla, Sumayyah

  • Manoj, Norwin

  • Patanwala, Azima Muzzammil

  • Premvignesh, Prasanna Appiya

  • Maher, Yamen

  • Majie, Ankit

  • Gorain, Bapi

  • Dutta, PhD, Sulagna

  • Sengupta, PhD, Pallav

  • Maldonado Rosas, Israel

  • Roychoudhury, Shubhadeep

  • April 9, 2026

  • 0 min

Share

Clinical Scorecard: The Role of Vitamin D, Myo-Inositol, and Melatonin in the Redox-Endocrine Network of PCOS: Exploring Their Potential Synergistic Effects

At a Glance

CategoryDetail
ConditionPolycystic ovary syndrome (PCOS), a heterogeneous endocrine–metabolic disorder
Key MechanismsSelf-perpetuating redox-endocrine network involving oxidative stress, hyperandrogenism, insulin resistance, and chronic inflammation
Target PopulationWomen with PCOS exhibiting reproductive dysfunction, insulin resistance, and metabolic impairment
Care SettingClinical endocrinology and metabolic disorder management settings

Key Highlights

  • Vitamin D modulates inflammatory tone and steroidogenic signaling via vitamin D receptor-dependent transcription and immune–metabolic crosstalk.
  • Myo-inositol restores insulin signaling through inositolphosphoglycan second-messenger pathways, reducing hyperinsulinemia-driven androgen excess.
  • Melatonin improves mitochondrial function, circadian regulation, and redox balance, converging on molecular hubs like NF-κB, Nrf2, PI3K/Akt, and AMPK.

Guideline-Based Recommendations

Diagnosis

  • Consider phenotype stratification and biomarker assessment including oxidative stress and endocrine markers for precise PCOS characterization.

Management

  • Supplementation with vitamin D, myo-inositol, and melatonin as a combined 'bioactive cocktail' targeting the redox-endocrine network.
  • Adopt a redox-guided, phenotype-aware framework for treatment planning.

Monitoring & Follow-up

  • Track ovulatory function, insulin resistance indices, oxidative stress biomarkers, and endocrine parameters to assess treatment response.

Risks

  • Heterogeneous clinical outcomes due to variability in dosing, treatment duration, and patient phenotype necessitate individualized monitoring.

Patient & Prescribing Data

Women diagnosed with PCOS exhibiting insulin resistance, hyperandrogenism, and oxidative stress-related metabolic disturbances.

Combined supplementation may improve ovulatory function, insulin sensitivity, and oxidative stress biomarkers; however, outcomes vary and require phenotype-specific dosing and duration adjustments.

Clinical Best Practices

  • Integrate vitamin D, myo-inositol, and melatonin supplementation to target interconnected molecular pathways in PCOS.
  • Employ biomarker-anchored and systems-level approaches for personalized treatment strategies.
  • Consider gut microbiota and adipokine profile modulation as part of comprehensive PCOS management.

Related Resources & Content

Original Source(s)

The Role of Vitamin D, Myo-Inositol, and Melatonin in the Redox-Endocrine Network of PCOS: Exploring Their Potential Synergistic Effects

  • by Subakathulla, Sumayyah , Manoj, Norwin , Patanwala, Azima Muzzammil, Premvignesh, Prasanna Appiya, Maher, Yamen , Majie, Ankit , Gorain, Bapi , Dutta, PhD, Sulagna , Sengupta, PhD, Pallav , Maldonado Rosas, Israel , Roychoudhury, Shubhadeep

  • April 9, 2026

Related Content

Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications

Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance

AutoPCOS: An Integrated Intelligent Framework for Risk Assessment and Diagnostic Assistance in Polycystic Ovary Syndrome